NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Collaborating Centre for Women's and Children's Health (UK). Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management. London: National Institute for Health and Care Excellence (UK); 2015 Aug. (NICE Guideline, No. 18.)
Update information November 2016: Recommendations 123 and 180 have been amended to add information on when eye screening should begin. Please note the date label of [2015] is unchanged, as this is when the recommendation was written and the evidence last reviewed. The changes made in November 2016 are clarifications of the 2015 wording, not new advice written in 2016, so do not carry a [2016] date.

Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management.
Show detailsAbbreviations from the 2004 guideline
Abbreviation | |
---|---|
CI | Confidence interval |
CGMS | Continuous glucose monitoring system |
CSII | Continuous subcutaneous insulin infusion |
DCCT | Diabetes Control and Complications Trial |
GDG | Guideline Development Group |
GPP | Good practice point |
GRP | Guideline Review Panel |
HbA1, HbA1c | Glycated haemoglobin |
IQ | Intelligence quotient |
LSHTM | London School of Hygiene and Tropical Medicine |
NCB | National Children's Bureau |
NCC-WCH | National Collaborating Centre for Women's and Children's Health |
NICE | National Institute for Clinical Excellence |
NICE TA | NICE Technology Appraisal |
NNT | Number needed to treat |
OGTT | Oral glucose tolerance test |
OR | Odds ratio |
QALY | Quality-adjusted life year |
RCT | Randomised controlled (clinical) trial |
RR | Relative risk (or risk ratio) |
SD | Standard deviation |
SE | Standard error |
WMD | Weighted mean difference |
Abbreviations and acronyms from the 2015 update
Abbreviation/acronym | Definition |
---|---|
3-OHB | 3-hydroxybutyrate |
Ab+ | Antibody positive |
ACE | Angiotensin converting enzyme |
ACR | Albumin:creatinine ratio |
ADA | American Diabetes Association |
AER | Albumin excretion rate |
AGREE | Appraisal of Guidelines for Research and Evaluation |
BDR | Background diabetic retinopathy |
BFST | Behavioural family systems therapy |
BMI | Body mass index |
BMI-SDS | Body mass index – standard deviation score |
BSPED | British Society for Paediatric Endocrinology and Diabetes |
CASCADE | Child and Adult Structured Competencies Approach to Diabetes Education |
CBT | Cognitive behavioural therapy |
CGMS | Continuous glucose monitoring system |
CHF | Chronic heart failure |
CI | Confidence interval |
CO2 | Carbon dioxide |
CSII | Continuous subcutaneous insulin infusion |
CST | Coping Skills Training |
CVD | Cardiovascular disease |
DCCT | Diabetes Control and Complications Trial |
DKA | Diabetic ketoacidosis |
DQOLY-SF | Diabetes Quality of Life for Youth – Short Form |
ECG | Electrocardiogram |
ECMO | Extracorporeal membrane oxygenation |
EDIC | Epidemiology of Diabetes Interventions and Complications |
EED | Economic Evaluation Database |
eGFR | Epidermal growth factor receptor |
ESRD | End-stage renal disease |
FPG | Fasting plasma glucose |
GAD | Anti-glutamic acid decarboxylase |
GAD65, GAD65+ | Glutamic acid decarboxylase autoantibody 65 (positive) |
GADA | Anti-glutamic acid decarboxylase antibody |
GP | General practitioner |
GRADE | Grading of Recommendations Assessment, Development and Evaluation |
GRP | Guideline review panel |
HAEM | Haemoglobin |
HbA1c | Glycated haemoglobin |
HDL | High-density lipoprotein |
HR | Hazard ratio |
HTA | Health Technology Assessment |
IAA | Insulin autoantibody |
IA-2 | Insulinoma-associated autoantibody |
IA-2A+ | Insulinoma-associated autoantibody-positive |
IA-2β-A | Insulinoma-associated beta autoantibody |
ICA | Islet-cell antibodies |
ICA512 | Anti-islet cell antibody 512 |
ICER | Incremental cost effectiveness ratio |
ICU | Intensive care unit |
IFCC | International Federation of Clinical Chemistry |
IGRP | Islet-specific glucose-6-phosphatase catalytic subunit |
IQR | Interquartile range |
ISPAD | International Society for Pedatric and Adolescent Diabetes |
ITU | Intensive care unit |
KICk-OFF | Kids In Control OF Food |
LADA | Latent autoimmune diabetes of adulthood |
LDL | Low-density lipoprotein |
LVH | Left ventricular hypertrophy |
MA | Microalbuminuria |
MCMC | Markov chain Monte Carlo |
MD | Mean difference |
MDI | Multiple daily injection |
ME | Macular oedema (edema) |
MI | Myocardial infarction; Multiple injections (see context) |
MID | Minimally important difference |
MIMS | Monthly Index of Medical Specialities |
MMTT | Mixed meal tolerance test |
MODY | Maturity onset diabetes of the young |
MRI | Magnetic resonance imaging |
MST | Multisystemic therapy |
NA | Not applicable |
NC | Not calculable |
NCC | National Collaborating Centre |
NCC-WCH | National Collaborating Centre for Women's and Children's Health |
NCGC | National Clinical Guideline Centre |
NHS | National Health Service |
NICE | National Institute for Health and Care Excellence |
NPH | neutral protamine Hagedorn |
NPSA | National Patient Safety Agency |
OR | Odds ratio |
PDR | Proliferative diabetic retinopathy |
PDSN | Paediatric diabetes specialist nurse |
PedsQL | Paediatric quality of life |
PSA | Probabilistic sensitivity analysis |
PVD | Peripheral vascular disease |
QALY | Quality adjusted life years |
QUADAS | Quality Assessment of Studies of Diagnostic Accuracy |
RCT | Randomised controlled trials |
RR | Relative risk |
SBP | Systolic blood pressure |
SD | Standard deviation |
SDS | Standard deviation score |
SMBG | Self-monitoring of blood glucose |
SMD | Standardised mean difference |
SVL | Severe visual loss |
T1D | Type 1 diabetes |
T2D | Type 2 diabetes |
TRIG | Triglycerides |
UCPCR | Urine C-peptide:creatinine ratio |
UKPDS | UK Prospective Diabetes Study |
VTE | Venous thromboembolism |
WBC | White blood cells |
- Abbreviations - Diabetes (Type 1 and Type 2) in Children and Young PeopleAbbreviations - Diabetes (Type 1 and Type 2) in Children and Young People
Your browsing activity is empty.
Activity recording is turned off.
See more...